Priyanka Rajan

This paper develops a sequential triple-drug strategy targeting p53 mutant cancers, showing it effectively induces cell death while minimizing toxicity to normal cells.

This study shows that blocking p38 reduces metastasis in breast cancer by reversing immune suppression in the tumor microenvironment, primarily through effects on CD8+ T cells and myeloid cells.

The paper compares the cellular response to DNA damage and chromatin damage using bleomycin and curaxin, finding distinct p53-dependent and -independent effects.